Alessio, Maria Grazia

Liver injury in COVID-19 and IL-6 trans-signaling-induced endotheliopathy

McConnell, M. J., Kawaguchi, N., Kondo, R., Sonzogni, A., Licini, L., Valle, C., Bonaffini, P. A., Sironi, S., Alessio, M. G., Previtali, G., et al. (2021) · Journal of Hepatology

COVID-19 Clinical Research StudiesDrug-Induced Hepatotoxicity and Protection

Cited by 111

Overcoming a “Probable” Diagnosis in Antimitochondrial Antibody Negative Primary Biliary Cirrhosis: Study of 100 Sera and Review of the Literature

Bizzaro, N., Covini, G., Rosina, F., Muratori, P., Tonutti, E., Villalta, D., Pesente, F., Alessio, M. G., Tampoia, M., Antico, A., et al. (2012) · Clinical Reviews in Allergy & Immunology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 79

Trend of Antitissue Transglutaminase Antibody Normalization in Children With Celiac Disease Started on Gluten‐free Diet: A Comparative Study Between Chemiluminescence and ELISA Serum Assays

Sansotta, N., Alessio, M. G., Norsa, L., Previtali, G., Ferrari, A., Guerra, G., & D'Antiga, L. (2020) · Journal of Pediatric Gastroenterology and Nutrition

Celiac Disease Research and ManagementEosinophilic Esophagitis

Cited by 31

Autoimmune hepatitis type 2 associated with an unexpected and transient presence of primary biliary cirrhosis-specific antimitochondrial antibodies: a case study and review of the literature

Invernizzi, P., Alessio, M. G., Smyk, D. S., Lleo, A., Sonzogni, A., Fabris, L., Candusso, M., Bogdanos, D. P., Iorio, R., & Torre, G. (2012) · BMC Gastroenterology

Liver Diseases and ImmunityPediatric Hepatobiliary Diseases and Treatments

Cited by 28

Comparison of current methods for anti‐dsDNA antibody detection and reshaping diagnostic strategies

Infantino, M., Palterer, B., Previtali, G., Alessio, M., Villalta, D., Carbone, T., Platzgummer, S., Paura, G., Castiglione, C., Fabris, M., et al. (2022) · Scandinavian Journal of Immunology

Systemic Lupus Erythematosus ResearchSystemic Sclerosis and Related Diseases

Cited by 20